News
PsychoGenics Highlights a Long-term Collaboration with the TSC Alliance on Rare Disease Day
Feb. 28, 2023 On this Rare Disease Day, we want to highlight and honor our long-term collaboration with the TSC...
News
PsychoGenics CEO Explores CNS Drug Development Trends
February 4, 2023 · By Brian Buntz · Drug Discovery & Development In the late 2000s, many companies, particularly Big...
News
Why the TAAR1 Agonist Ulotaront Holds Promise for Schizophrenia
November 22, 2022 · By Brian Buntz · Drug Discovery & Development